Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing TONKA to Legalon for lowering hepatic enzymes in patients with liver function failure; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Legalon (silymarin)
  • TONKA

Snippet

Sponsor: Nhat Nhat Pharmaceutical Company | Conditions: Liver Function Failure | Phase 3 | Status: UNKNOWN